Dr. Gregory A. Yanik

Claim this profile

University of Michigan Health

Studies Acute Myelogenous Leukemia
Studies Leukemia
3 reported clinical trials
4 drugs studied

Area of expertise

1

Acute Myelogenous Leukemia

Gregory A. Yanik has run 2 trials for Acute Myelogenous Leukemia. Some of their research focus areas include:

CD33 positive
Stage II
Stage I
2

Leukemia

Gregory A. Yanik has run 2 trials for Leukemia. Some of their research focus areas include:

CD33 positive
HLA negative
RB1 positive

Affiliated Hospitals

Image of trial facility.

University Of Michigan Health

Image of trial facility.

C S Mott Children's Hospital

More about Gregory A. Yanik

Clinical Trial Related

7 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 0 Active Clinical Trials

Treatments Gregory A. Yanik has experience with

  • VCAR33
  • Lactobacillus Plantarum
  • Haploidentical Hematopoietic Cell Transplantation (haploHCT)
  • Matched Unrelated Donor Hematopoietic Cell Transplantation (MUD-HCT)

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Gregory A. Yanik specialize in?

Is Gregory A. Yanik currently recruiting for clinical trials?

Are there any treatments that Gregory A. Yanik has studied deeply?

What is the best way to schedule an appointment with Gregory A. Yanik?

What is the office address of Gregory A. Yanik?

Is there any support for travel costs?

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.

Terms of Service·Privacy Policy·Cookies·Security